187 related articles for article (PubMed ID: 38239348)
1. P2Y
Oliveira NF; Monteiro MMLV; Mainieri NS; Tamura AS; Pereira LM; Crepaldi LD; Coutinho-Silva R; Savio LEB; Silva CLM
Front Immunol; 2023; 14():1328897. PubMed ID: 38239348
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of NTPDases 2 and 3 in mesenteric endothelial cells during schistosomiasis favors leukocyte adhesion through P2Y1 receptors.
Oliveira SD; Oliveira NF; Meyer-Fernandes JR; Savio LE; Ornelas FG; Ferreira ZS; Coutinho-Silva R; Silva CL
Vascul Pharmacol; 2016 Jul; 82():66-72. PubMed ID: 26924460
[TBL] [Abstract][Full Text] [Related]
3. P2Y(2)R activation by nucleotides released from oxLDL-treated endothelial cells (ECs) mediates the interaction between ECs and immune cells through RAGE expression and reactive oxygen species production.
Eun SY; Park SW; Lee JH; Chang KC; Kim HJ
Free Radic Biol Med; 2014 Apr; 69():157-66. PubMed ID: 24486339
[TBL] [Abstract][Full Text] [Related]
4. P2Y
Jin H; Ko YS; Park SW; Kim HJ
Free Radic Biol Med; 2019 May; 136():109-117. PubMed ID: 30959169
[TBL] [Abstract][Full Text] [Related]
5. Activation of endothelial NO synthase and P2X7 receptor modification mediates the cholinergic control of ATP-induced interleukin-1β release by mononuclear phagocytes.
Richter K; Asci N; Singh VK; Yakoob SH; Meixner M; Zakrzewicz A; Liese J; Hecker A; Wilker S; Stumpf S; Schlüter KD; Rohde M; Gödecke A; Padberg W; Manzini I; Schmalzing G; Grau V
Front Immunol; 2023; 14():1140592. PubMed ID: 36969210
[TBL] [Abstract][Full Text] [Related]
6. Endothelial P2X7 receptors' expression is reduced by schistosomiasis.
Oliveira SD; Coutinho-Silva R; Silva CL
Purinergic Signal; 2013 Mar; 9(1):81-9. PubMed ID: 22987361
[TBL] [Abstract][Full Text] [Related]
7. P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells.
Jin H; Eun SY; Lee JS; Park SW; Lee JH; Chang KC; Kim HJ
Breast Cancer Res; 2014 Aug; 16(5):R77. PubMed ID: 25156554
[TBL] [Abstract][Full Text] [Related]
8. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
[TBL] [Abstract][Full Text] [Related]
9. The blockage of downstream P2Y
Cardoso TC; Rocha MA; Monteiro MMLV; Alves VS; Savio LEB; Silva CLM
Life Sci; 2022 Oct; 306():120793. PubMed ID: 35850244
[TBL] [Abstract][Full Text] [Related]
10. Purinergic P2X7 Receptor Mediates the Elimination of Trichinella spiralis by Activating NF-κB/NLRP3/IL-1β Pathway in Macrophages.
Guan F; Jiang W; Bai Y; Hou X; Jiang C; Zhang C; Jacques ML; Liu W; Lei J
Infect Immun; 2021 Apr; 89(5):. PubMed ID: 33558327
[TBL] [Abstract][Full Text] [Related]
11. High-affinity P2Y2 and low-affinity P2X7 receptor interaction modulates ATP-mediated calcium signaling in murine osteoblasts.
Mikolajewicz N; Smith D; Komarova SV; Khadra A
PLoS Comput Biol; 2021 Jun; 17(6):e1008872. PubMed ID: 34153025
[TBL] [Abstract][Full Text] [Related]
12. P2Y
Thorstenberg ML; Martins MDA; Figliuolo V; Silva CLM; Savio LEB; Coutinho-Silva R
Mediators Inflamm; 2020; 2020():2545682. PubMed ID: 33061823
[TBL] [Abstract][Full Text] [Related]
13. P2X7 Receptor-Induced Bone Cancer Pain by Regulating Microglial Activity via NLRP3/IL-1beta Signaling.
Wu P; Wu X; Zhou G; Wang Y; Liu X; Lv R; Liu Y; Wen Q
Pain Physician; 2022 Nov; 25(8):E1199-E1210. PubMed ID: 36375190
[TBL] [Abstract][Full Text] [Related]
14. Unveiling the Potential of Purinergic Signaling in Schistosomiasis Treatment.
Oliveira NF; Silva CLM
Curr Top Med Chem; 2021; 21(3):193-204. PubMed ID: 32972342
[TBL] [Abstract][Full Text] [Related]
15. Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts.
Korcok J; Raimundo LN; Ke HZ; Sims SM; Dixon SJ
J Bone Miner Res; 2004 Apr; 19(4):642-51. PubMed ID: 15005852
[TBL] [Abstract][Full Text] [Related]
16. Purinergic P2Y2 Receptor Control of Tissue Factor Transcription in Human Coronary Artery Endothelial Cells: NEW AP-1 TRANSCRIPTION FACTOR SITE AND NEGATIVE REGULATOR.
Liu Y; Zhang L; Wang C; Roy S; Shen J
J Biol Chem; 2016 Jan; 291(4):1553-1563. PubMed ID: 26631725
[TBL] [Abstract][Full Text] [Related]
17. Blocking of the P2X7 receptor inhibits the activation of the MMP-13 and NF-κB pathways in the cartilage tissue of rats with osteoarthritis.
Hu H; Yang B; Li Y; Zhang S; Li Z
Int J Mol Med; 2016 Dec; 38(6):1922-1932. PubMed ID: 27748894
[TBL] [Abstract][Full Text] [Related]
18. IL-1β enhances vascular smooth muscle cell proliferation and migration via P2Y2 receptor-mediated RAGE expression and HMGB1 release.
Eun SY; Ko YS; Park SW; Chang KC; Kim HJ
Vascul Pharmacol; 2015 Sep; 72():108-17. PubMed ID: 25956731
[TBL] [Abstract][Full Text] [Related]
19. Differential nuclear factor-kappa B phosphorylation induced by lipopolysaccharide in the hippocampus of P2X7 receptor knockout mouse.
Kim WI; Ryu HJ; Kim JE; Seo CH; Lee BC; Choi IG; Kang TC
Neurol Res; 2013 May; 35(4):369-81. PubMed ID: 23540405
[TBL] [Abstract][Full Text] [Related]
20. P2Y2 nucleotide receptor mediates arteriogenesis in a murine model of hind limb ischemia.
McEnaney RM; Shukla A; Madigan MC; Sachdev U; Tzeng E
J Vasc Surg; 2016 Jan; 63(1):216-25. PubMed ID: 25088742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
